RR
Rameez Rasool
About Rameez Rasool
Data last updated:
Rameez Rasool has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Crestcare Diagnostics And Multispeciality Centre Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Crestcare Diagnostics And Multispeciality Centre Private Limited at ₹1.32 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Nov 2020 | 2020 | ₹1.32 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rameez Rasool
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rameez Rasool
Rameez Rasool has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Crestcare Diagnostics And Multispeciality Centre Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Crestcare Diagnostics And Multispeciality Centre Private Limited at ₹1.32 Cr (FY 2023).
Rameez Rasool is associated with 1 company as Director, including Crestcare Diagnostics And Multispeciality Centre Private Limited (₹1.32 Cr).
Rameez Rasool has expertise in General Business.
Rameez Rasool has 5 years in corporate governance.
By reported revenue, the largest current company of Rameez Rasool is Crestcare Diagnostics And Multispeciality Centre Private Limited, with revenue of ₹1.32 Cr (FY 2023).
Rameez Rasool currently holds positions at 1 company: Crestcare Diagnostics And Multispeciality Centre Private Limited (₹1.32 Cr).